|
Immunotherapy
Citations 51-60 of 577 total displayed.
|
Past content
(since Jun 2000):
|
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
- Kathy Fernando, Haitao Hu, Houping Ni, James A. Hoxie, and Drew Weissman
Blood 2007; 109: 2538-2544.
[Abstract]
[Full text]
[PDF]
The growth factor fusion construct containing B-lymphocyte stimulator (BLyS) and the toxin rGel induces apoptosis specifically in BAFF-R–positive CLL cells
- Ramadevi Nimmanapalli, Mi-Ae Lyu, Min Du, Michael J. Keating, Michael G. Rosenblum, and Varsha Gandhi
Blood 2007; 109: 2557-2564.
[Abstract]
[Full text]
[PDF]
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease
- Margaret L. MacMillan, Daniel Couriel, Daniel J. Weisdorf, Gisela Schwab, Nancy Havrilla, Thomas R. Fleming, Saling Huang, Lorin Roskos, Shimon Slavin, Richard K. Shadduck, John DiPersio, Mary Territo, Steve Pavletic, Charles Linker, Helen E. Heslop, H. Joachim Deeg, and Bruce R. Blazar
Blood 2007; 109: 2657-2662.
[Abstract]
[Full text]
[PDF]
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
- Hisaki Fujii, Jacqueline D. Trudeau, David T. Teachey, Jonathan D. Fish, Stephan A. Grupp, Kirk R. Schultz, and Gregor S. D. Reid
Blood 2007; 109: 2008-2013.
[Abstract]
[Full text]
[PDF]
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
- Shmuel Yaccoby, Wen Ling, Fenghuang Zhan, Ronald Walker, Bart Barlogie, and John D. Shaughnessy, Jr
Blood 2007; 109: 2106-2111.
[Abstract]
[Full text]
[PDF]
Humoral immune response and immunoglobulin G Fc receptor genotype are associated with better clinical outcome following idiotype vaccination in follicular lymphoma patients regardless of their response to induction chemotherapy
- Wen-Kai Weng, Debra Czerwinski, and Ronald Levy
Blood 2007; 109: 951-953.
[Abstract]
[Full text]
[PDF]
Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
- Djordje Atanackovic, Julia Arfsten, Yanran Cao, Sacha Gnjatic, Frank Schnieders, Katrin Bartels, Georgia Schilling, Christiane Faltz, Christine Wolschke, Judith Dierlamm, Gerd Ritter, Thomas Eiermann, Dieter Kurt Hossfeld, Axel R. Zander, Achim A. Jungbluth, Lloyd J. Old, Carsten Bokemeyer, and Nicolaus Kröger
Blood 2007; 109: 1103-1112.
[Abstract]
[Full text]
[PDF]
Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor
- Yumiko Wada, Rongzhen Lu, Dan Zhou, John Chu, Teresa Przewloka, Shijie Zhang, Long Li, Yaming Wu, June Qin, Vishwasenani Balasubramanyam, James Barsoum, and Mitsunori Ono
Blood 2007; 109: 1156-1164.
[Abstract]
[Full text]
[PDF]
Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities
- Julie A. McEarchern, Ezogelin Oflazoglu, Leigh Francisco, Charlotte F. McDonagh, Kristine A. Gordon, Ivan Stone, Kerry Klussman, Eileen Turcott, Nico van Rooijen, Paul Carter, Iqbal S. Grewal, Alan F. Wahl, and Che-Leung Law
Blood 2007; 109: 1185-1192.
[Abstract]
[Full text]
[PDF]
Continuous delivery of human type I interferons ( /ß) has significant activity against acute myeloid leukemia cells in vitro and in a xenograft model
- Reuben Benjamin, Asim Khwaja, Nalini Singh, Jenny McIntosh, Anthony Meager, Meenu Wadhwa, Christian Streck, Catherine Ng, Andrew M. Davidoff, and Amit C. Nathwani
Blood 2007; 109: 1244-1247.
[Abstract]
[Full text]
[PDF]
|
|
